Events & presentations

Internal link Webcast of Presentation of QR-421a Phase 1/2 Stellar Trial Results

Company management will present and discuss results from its Phase 1/2 Stellar trial of QR-421a in adults with Usher syndrome and non-syndromic retinitis pigmentosa (nsRP).

• Add Webcast of Presentation of QR-421a Phase 1/2 Stellar Trial Results to calender

Internal link JMP Securities Grand Rounds KOL Call | PRQR Phase 1/2 Stellar Data in Usher Syndrome

Featuring Dr. David Birch, Ph.D.
Hosted by JMP Securities Biotech Analyst Jonathan Wolleben

• Add JMP Securities Grand Rounds KOL Call | PRQR Phase 1/2 Stellar Data in Usher Syndrome to calender

Internal link HC Wainwright Global Life Sciences Conference

ProQR's participation in HC Wainwright's Global Life Sciences Conference (virtual).

• Add HC Wainwright Global Life Sciences Conference to calender

Internal link Rare Disease Day

Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives.

• Add Rare Disease Day to calender

Internal link Expert Perspectives Series - Disease Education and Endpoints in Usher Syndrome

Aniz Girach, MD, Chief Medical Officer, and Paul Yang, MD, PhD, Casey Eye Institute will discuss which vision measures are most informative in Usher syndrome, the role of baseline and disease progression, and objectives of the Stellar trial.

• Add Expert Perspectives Series - Disease Education and Endpoints in Usher Syndrome to calender